Epilepsy  >>  Synacthen Depot (cosyntropin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Synacthen Depot (cosyntropin) / Novartis, Mallinckrodt, Alliance
2006-000788-27: International Collaborative Infantile Spasms Study (ICISS)

Ongoing
4
200
Europe
SABRIL SACHETS, SYNACTHEN DEPOT, SOLUBLE PREDNISOLONE TABLETS, SABRIL SACHETS, SYNACTHEN DEPOT, SOLUBLE PREDNISOLONE TABLETS
Royal United Hospital Bath NHS Trust, , Castang Foundation, NIHR, Bath Unit for Research in Paediatrics, Bronner/Bender Stiftung
Infantile spasms are a rare severe form of epilepsy affecting approx 1 in 2,250 infants, usually under the age of 1 year. Affected infants have a very abnormal EEG and a poor prognosis for subsequent epilepsy and neuro-development. There is a high risk of underlying neurological disease that independently causes delayed development and other seizure disorders. There is a high risk of a poor outcome even when there is no other detectable underlying neurological disorder.
 
 

Download Options